In Sost−/− mice, Wnt signaling and bone mass was increased [23], whereas transgenic mice over-expressing Sost in bone tissue had osteopenia [24], indicating that Sclerostin is an important negative regulator of bone formation. Here, SOST is linked to Osteopenia.